Post
-
National Cancer Institute director details bridge to the future of cancer care
Norman E. Sharpless, MD, told AACR Annual Meeting 2021 attendees that this is the golden age of cancer care, but many of the biggest challenges still remain.
-
Session focuses on molecular approaches to precision prevention of cancer
Presenters (clockwise, from top left) Adriana Albini, PhD, Andrew J. Dannenberg, MD, Victoria Seewaldt, MD, and Cory Abate-Shen, PhD, also participated in a panel.
-
Panelists explore diagnostic approaches, replication stress, and resistance mechanisms to DDR-targeting therapies
The session and related panel discussion featured (from left) Joaquin Mateo, MD, PhD, Mark J. O’Connor, PhD, and Fiona Simpkins, MD.
-
New approaches exploit cell plasticity to reduce resistance to cancer therapies
(From left) Owen N. Witte, MD, Mark A. Rubin, PhD, and Paul Smith, BSc, PhD, were the presenters in this session.
-
Symposium examines intricacies of the premetastatic niche
(From left) David Lyden, MD, PhD, Dihua Yu, MD, PhD, and Xuetao Cao, MD, PhD, shared insights from their research in this area.
-
Forum participants consider role of cancer stem cells
(From left) Irving Weissman, MD, John E. Dick, PhD, and Sean J. Morrison, PhD, were speakers during the forum that included presentations and a panel discussion.
-
Early studies show changes in diet, circadian rhythms could impact tumor growth
The symposium featured (from left) Katja A. Lamia, PhD, Satchidananda Panda, PhD, and Joshua D. Rabinowitz, MD, PhD.